(11beta,20S)-11,17,20,21-Tetrahydroxypregna-1,4-dien-3-one(CAS: 2299-46-9)

The compound (11beta,20S)-11,17,20,21-Tetrahydroxypregna-1,4-dien-3-one (CAS: 2299-46-9) is subject to various regulatory guidelines, including GHS classification for hazardous substances, REACH regulations for the European market, and FDA/EPA requirements for safety and environmental impact. It is important to comply with local and international regulations to ensure the safe handling and transportation of this compound.

There are several alternatives to (11beta,20S)-11,17,20,21-Tetrahydroxypregna-1,4-dien-3-one (CAS: 2299-46-9) in synthesis, including similar steroid compounds and their analogs. Common alternatives include other 17,20-estradiol derivatives and other steroid hormones. These substitutes can provide similar or enhanced functionality in various applications, depending on the specific requirements of the synthesis process.

The market for (11beta,20S)-11,17,20,21-Tetrahydroxypregna-1,4-dien-3-one (CAS: 2299-46-9) is experiencing steady growth, driven by increasing research in hormone therapy and related medical applications. Emerging trends include the development of more targeted and efficient synthesis methods, as well as the exploration of this compound in novel drug delivery systems and personalized medicine solutions.

Waste containing (11beta,20S)-11,17,20,21-Tetrahydroxypregna-1,4-dien-3-one (CAS: 2299-46-9) should be handled in accordance with local and international waste management regulations. This typically involves proper collection in sealed containers, followed by incineration or professional disposal services to ensure environmental protection. It is crucial to follow safety protocols and consult with environmental protection agencies to ensure compliance with all relevant regulations.